Literature DB >> 30587363

The challenges of using the Hospital Frailty Risk Score - Author's reply.

Simon Conroy1, Thomas Gilbert2, Andrew Street3, Helen C Roberts4, Stuart Parker5.   

Abstract

Mesh：

Year:  2018        PMID： 30587363     DOI： 10.1016/S0140-6736(18)33194-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan.

Authors:  Yumina Muto; Shintaro Narita; Shingo Hatakeyama; Shinya Maita; Shuji Chiba; Kyohei Kubo; Yuu Aoyama; Ryuichi Ito; Yoshiko Takahashi; Shuhei Takahashi; Kumiko Nakamura; Naoko Honma; Hiromi Sato; Atsushi Koizumi; Ryoma Igarashi; Katsumi Okane; Toshiya Ishida; Yohei Horikawa; Teruaki Kumazawa; Susumu Akihama; Jiro Shimoda; Takehiro Suzuki; Chikara Ohyama; Tomonori Habuchi
Journal:  Med Oncol       Date:  2021-03-13       Impact factor: 3.064

2.  Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy.

Authors:  Shintaro Narita; Takahiro Kimura; Shingo Hatakeyama; Kenichi Hata; Takafumi Yanagisawa; Shinya Maita; Shuji Chiba; Hiromi Sato; Soki Kashima; Atsushi Koizumi; Ryohei Yamamoto; Koichiro Takayama; Katsumi Okane; Toshiya Ishida; Yohei Horikawa; Teruaki Kumazawa; Jiro Shimoda; Takehiro Suzuki; Chikara Ohyama; Shin Egawa; Kyoko Nomura; Tomonori Habuchi
Journal:  World J Urol       Date:  2022-02-26       Impact factor: 4.226

3.  Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel.

Authors:  Shintaro Narita; Takahiro Kimura; Shingo Hatakeyama; Kenichi Hata; Takafumi Yanagisawa; Shinya Maita; Shuji Chiba; Hiromi Sato; Soki Kashima; Atsushi Koizumi; Ryohei Yamamoto; Koichiro Takayama; Katsumi Okane; Toshiya Ishida; Yohei Horikawa; Teruaki Kumazawa; Jiro Shimoda; Takehiro Suzuki; Chikara Ohyama; Shin Egawa; Tomonori Habuchi
Journal:  Int J Clin Oncol       Date:  2022-06-24       Impact factor: 3.850

4.  Hospital frailty risk score predicts adverse events in spine surgery.

Authors:  Loreto C Pulido; Matthias Meyer; Jan Reinhard; Tobias Kappenschneider; Joachim Grifka; Markus Weber
Journal:  Eur Spine J       Date:  2022-04-18       Impact factor: 2.721
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.